|
Volumn 26, Issue 3 SUPPL. 9, 1999, Pages 24-31
|
The role of docetaxel (taxotere) in neoadjuvant chemotherapy of breast cancer
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOCETAXEL;
DOXORUBICIN;
FLUOROURACIL;
GRANULOCYTE COLONY STIMULATING FACTOR;
PREDNISOLONE;
SEROTONIN ANTAGONIST;
TAMOXIFEN;
VINCRISTINE;
ADVANCED CANCER;
ALOPECIA;
ARTICLE;
BLOOD TOXICITY;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG POTENCY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METASTASIS;
NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
SKIN TOXICITY;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ANTHRACYCLINES;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
HUMANS;
NEOPLASM METASTASIS;
PACLITAXEL;
TAXOIDS;
|
EID: 0032788509
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (27)
|
References (21)
|